The National Comprehensive Cancer Network (NCCN) and the NCCN Foundation announce four recipients for the 2025 NCCN Foundation Young Investigator Awards (YIA).
The National Comprehensive Cancer Network聽(NCCN)鈥攁n alliance of leading cancer centers鈥攃elebrated 30 years of helping people with cancer to live better lives during the NCCN 2025 Annual Conference, March 28-30 in Orlando, Florida. The yearly event brings together leading minds and subject matter experts in front of a multidisciplinary audience to share the latest recommendations for cancer treatment and prevention.
New patient webinar from NCCN Foundation addresses: 1. What is the Purpose of Cancer Clinical Trials? 2. What is the Role of Clinical Trials in Cancer Treatment, Including Risks and Benefits? 3. How do you Access Cancer Clinical Trials?
The National Comprehensive Cancer Network (NCCN) Oncology Research Program (ORP) announces new funding aimed at advancing clinical research in gastrointestinal cancers.
Some patient advocates from the NCCN Guidelines Panels who make evidence-based expert consensus-driven recommendations for cancer prevention, treatment, and supportive care are sharing their unique stories in honor of this year鈥檚 World Cancer Day.
NCCN鈥攁n alliance of leading cancer centers鈥攑ublishes a new resource to inform people about the latest recommendations around hereditary and familial cancer risk.
A meeting at the Middle East North Africa (MENA)-NCCN Regional Coordinating Center聽presents new and updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines庐): MENA Editions, and selected topics highlighting cancer advances, challenges, and opportunities in the region.
The NCCN Oncology Research Program (ORP) announces funding of a project that will underpin innovative research on optimal management of side effects secondary to treatment with poly ADP ribose polymerase inhibitors (PARPi).
NCCN hosts a Patient Advocacy Summit bringing together leading experts to promote strategies and best practices for improving cancer care, focused on practice and policy solutions for sharing accurate, evidence-based health information with patients and caregivers.
The NCCN Oncology Research Program (ORP) announces the awarding of new quality improvement research grants aimed at advancing care for patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL).
The National Comprehensive Cancer Network (NCCN) is honored to participate in 2024 CCHIO. NCCN has taken numerous strides in recent years to increase the global accessibility and relevance of NCCN Guidelines as a tool for helping people with cancer to live better lives, including multiple collaborations with leading oncology groups in China.
Newly-published NCCN Guidelines for Patients: Quitting Smoking explains what the evidence and expert consensus is on how to best use the tools that exist to help anyone quit for good.
NCCN expands guidelines to create two major resources for helping cancer care providers and other stakeholders stay current on cutting edge research on genetic/familial high-risk assessment.
Leaders from the National Comprehensive Cancer Network (NCCN) travel to Vietnam to collaborate with Vietnam National Cancer Hospital on improving cancer care standards throughout the country.
International oncology experts gather in Accra, Ghana for a series of meetings to update cancer treatment recommendations in the NCCN Harmonized Guidelines鈩� for Sub-Saharan Africa.
National Comprehensive Cancer Network (NCCN) presents preliminary data from a study demonstrating the usability of the Health Equity Report Card (HERC) tool during the American Public Health Association (APHA) Annual Meeting and Expo.
New study in JNCCN-Journal of the National Comprehensive Cancer Network that finds that people diagnosed with an aggressive breast cancer subtype (HR-negative, HER2-positive) are more likely to live longer in states that participate in Medicaid expansion under the Affordable Care Act (ACA).
NCCN announces a renewed collaboration with LACOG to publish new NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer: Brazil Edition. Additional Brazilian adaptations of NCCN Guidelines for other cancer types are planned for the future.
The National Comprehensive Cancer Network (NCCN) and the NCCN Foundation announce plans to make every book in the library of NCCN Guidelines for Patients available in Spanish; with select editions available in additional languages as well.
Speakers at an NCCN Oncology Policy Summit discuss the importance of diversity, equity, and inclusion (DEI) as integral to the oncology workforce to improve cancer outcomes, and what to do about backlash.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 麻豆传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right